Insider Trades51 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 700 | $3.21 | $191.7M | -78.95% | +1.36% | $2.2K | -0.25% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Antonio S. Montecalvo | Vice President, Health Policy | 3,741 | $3.84 | $191.7M | -78.95% | +1.36% | $14.4K | -1.48% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Antonio S. Montecalvo | Vice President, Health Policy | 3,778 | $3.84 | $191.7M | -78.95% | +1.36% | $14.5K | -1.64% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 5,432 | $3.84 | $191.7M | -78.95% | +1.36% | $20.9K | -1.62% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 5,487 | $3.84 | $191.7M | -78.95% | +1.36% | $21.1K | -1.95% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Brian Grow | Chief Commercial Officer | 11,768 | $3.84 | $191.7M | -78.95% | +1.36% | $45.2K | -1.13% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Brian Grow | Chief Commercial Officer | 11,887 | $3.84 | $191.7M | -78.95% | +1.36% | $45.6K | -1.30% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 14,267 | $3.84 | $191.7M | -78.95% | +1.36% | $54.8K | -1.24% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 14,411 | $3.84 | $191.7M | -78.95% | +1.36% | $55.3K | -1.39% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | David Francisco | Chief Financial Officer | 14,541 | $3.84 | $191.7M | -78.95% | +1.36% | $55.8K | -1.70% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | David Francisco | Chief Financial Officer | 14,687 | $3.84 | $191.7M | -78.95% | +1.36% | $56.4K | -1.97% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Patrick Bilbo | Chief Operating Officer | 16,212 | $3.84 | $191.7M | -78.95% | +1.36% | $62.3K | -1.28% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Patrick Bilbo | Chief Operating Officer | 16,375 | $3.84 | $191.7M | -78.95% | +1.36% | $62.9K | -1.43% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 90,398 | $3.84 | $191.7M | -78.95% | +1.36% | $347.1K | -1.87% | — | Sell Now |
| Feb 18, 2026 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 91,311 | $3.84 | $191.7M | -78.95% | +1.36% | $350.6K | -2.11% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 17,658 | $3.73 | $191.7M | -78.95% | +1.36% | $65.9K | -3.22% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | Antonio S. Montecalvo | Vice President, Health Policy | 18,619 | $3.73 | $191.7M | -78.95% | +1.36% | $69.4K | -2.45% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | Brian Grow | Chief Commercial Officer | 43,959 | $3.73 | $191.7M | -78.95% | +1.36% | $164.0K | -1.67% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | David Francisco | Chief Financial Officer | 52,448 | $3.73 | $191.7M | -78.95% | +1.36% | $195.6K | -2.42% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 54,742 | $3.73 | $191.7M | -78.95% | +1.36% | $204.2K | -1.65% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | Patrick Bilbo | Chief Operating Officer | 64,414 | $3.73 | $191.7M | -78.95% | +1.36% | $240.3K | -1.74% | — | Sell Now |
| Feb 15, 2026 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 271,406 | $3.73 | $191.7M | -78.95% | +1.36% | $1.0M | -1.97% | — | Sell Now |
| Aug 11, 2025 | Buy | ORGO | Brian Grow | Chief Commercial Officer | 6,233 | $3.22 | $191.7M | -78.95% | +1.36% | $20.1K | +0.14% | — | Sell Now |
| Jul 16, 2025 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 360 | $4.46 | $191.7M | -78.95% | +1.36% | $1.6K | -0.19% | — | Sell Now |
| Jun 4, 2025 | Buy | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 252,264 | $2.88 | $191.7M | -78.95% | +1.36% | $725.3K | +11.86% | — | Sell Now |
| Mar 9, 2025 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 271 | $5.16 | $191.7M | -78.95% | +1.36% | $1.4K | -0.07% | — | Sell Now |
| Mar 1, 2025 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 667 | $6.21 | $191.7M | -78.95% | +1.36% | $4.1K | -0.35% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 11,008 | $3.70 | $191.7M | -78.95% | +1.36% | $40.7K | -4.01% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | Antonio S. Montecalvo | Vice President, Health Policy | 14,081 | $3.70 | $191.7M | -78.95% | +1.36% | $52.1K | -2.19% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | Brian Grow | Chief Commercial Officer | 33,386 | $3.70 | $191.7M | -78.95% | +1.36% | $123.5K | -1.66% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | David Francisco | Chief Financial Officer | 35,057 | $3.70 | $191.7M | -78.95% | +1.36% | $129.7K | -2.14% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 37,124 | $3.70 | $191.7M | -78.95% | +1.36% | $137.4K | -2.07% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | Patrick Bilbo | Chief Operating Officer | 44,156 | $3.70 | $191.7M | -78.95% | +1.36% | $163.4K | -1.41% | — | Sell Now |
| Feb 15, 2025 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 232,086 | $3.70 | $191.7M | -78.95% | +1.36% | $858.7K | -1.99% | — | Sell Now |
| Jan 10, 2025 | Buy | ORGO | Brian Grow | Chief Commercial Officer | 958 | $1.24 | $191.7M | -78.95% | +1.36% | $1.2K | +0.11% | — | Sell Now |
| Dec 13, 2024 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 61,200 | $3.37 | $191.7M | -78.95% | +1.36% | $206.4K | -1.00% | — | Sell Now |
| Dec 10, 2024 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 259,332 | $3.62 | $191.7M | -78.95% | +1.36% | $940.1K | -2.64% | — | Sell Now |
| Dec 5, 2024 | Buy | ORGO | Gary S. Gillheeney | President and CEO | 1,126,713 | $1.13 | $191.7M | -78.95% | +1.36% | $1.3M | +10.99% | — | Sell Now |
| Jul 16, 2024 | Sell | ORGO | Robert Cavorsi | Vice President, Strategy | 317 | $3.09 | $191.7M | -78.95% | +1.36% | $979.53 | -0.23% | — | Sell Now |
| Apr 1, 2024 | Sell | ORGO | Antonio S. Montecalvo | Vice President, Health Policy | 1,752 | $2.80 | $191.7M | -78.95% | +1.36% | $4.9K | -1.03% | — | Sell Now |
| Apr 1, 2024 | Sell | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 1,974 | $2.80 | $191.7M | -78.95% | +1.36% | $5.5K | -0.42% | — | Sell Now |
| Apr 1, 2024 | Sell | ORGO | Brian Grow | Chief Commercial Officer | 1,977 | $2.80 | $191.7M | -78.95% | +1.36% | $5.5K | -0.38% | — | Sell Now |
| Apr 1, 2024 | Sell | ORGO | Patrick Bilbo | Chief Operating Officer | 2,497 | $2.80 | $191.7M | -78.95% | +1.36% | $7.0K | -0.31% | — | Sell Now |
| Apr 1, 2024 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 10,113 | $2.80 | $191.7M | -78.95% | +1.36% | $28.3K | -0.43% | — | Sell Now |
| Mar 28, 2024 | Buy | ORGO | Patrick Bilbo | Chief Operating Officer | 152,250 | $1.18 | $191.7M | -78.95% | +1.36% | $179.7K | +23.09% | — | Sell Now |
| Feb 15, 2024 | Sell | ORGO | Antonio S. Montecalvo | Vice President, Health Policy | 10,628 | $3.67 | $191.7M | -78.95% | +1.36% | $39.0K | -2.71% | — | Sell Now |
| Feb 15, 2024 | Sell | ORGO | Brian Grow | Chief Commercial Officer | 22,883 | $3.67 | $191.7M | -78.95% | +1.36% | $84.0K | -2.13% | — | Sell Now |
| Feb 15, 2024 | Sell | ORGO | David Francisco | Chief Financial Officer | 23,283 | $3.67 | $191.7M | -78.95% | +1.36% | $85.5K | -2.79% | — | Sell Now |
| Feb 15, 2024 | Sell | ORGO | Lori Freedman | Chief Admin. and Legal Officer | 25,805 | $3.67 | $191.7M | -78.95% | +1.36% | $94.8K | -2.62% | — | Sell Now |
| Feb 15, 2024 | Sell | ORGO | Patrick Bilbo | Chief Operating Officer | 30,324 | $3.67 | $191.7M | -78.95% | +1.36% | $111.4K | -2.09% | — | Sell Now |
| Feb 15, 2024 | Sell | ORGO | Gary S. Gillheeney | President and CEO | 91,001 | $3.67 | $191.7M | -78.95% | +1.36% | $334.1K | -1.77% | — | Sell Now |